Navigation Links
Alkermes in Medical News

Weekly Drug Helps Type 2 Diabetics

...aceuticals Inc., the maker of Byetta, is working with Eli Lilly and Co. and alkermes Inc. to develop exenatide once weekly. More than 21 million people in th... SOURCE: Amylin Pharmaceuticals Inc., Eli Lilly and Co., alkermes Inc., news release, June 9, 2008 ...

Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy

...nhaled insulin program. A two-year safety trial and other studies are ongoing for both the inhaled insulin formulation and device. Lilly and alkermes currently expect regulatory submission to the FDA in 2009. -- Arzoxifene - A Phase III osteoporosis prevention trial that enrolled over 30...

Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study

... http://www.BYETTA.com . About Amylin, Lilly, and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide long-act...mprove the lives of patients with serious disease. alkermes currently has two commercial products: RISPERDAL(R...

Drug Approved to Curb Alcohol Dependency

...rs while acamprosate has its effect on a neurotransmitter. They both have been approved by Food and Drug Administration approval. Naltrexone, made by alkermes Inc. as an injectable form, to be taken monthly, will be marketed by Cephalon Inc. The results of the study have been published in the Journal o...

Alcoholism Drug Vivitrol Approved By FDA

...ypersensitivity to naltrexone, PLG or any other components of the diluent," alkermes and Cephalon said in a statement. Patients must be opioid free for at least...hould be monitored for the development of depression or suicidal thinking," alkermes and Cephalon said. Some 18 million Americans abuse or are dependent o...
Alkermes in Medical Technology

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

...control.(vi,vii) About Amylin, Lilly and alkermes Amylin, Lilly and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

...addiction. The family of compounds was licensed to alkermes Inc., and the company identified a lead product ca...granting Massachusetts-based biotechnology company alkermes exclusive rights to a library of compounds discove...diction, pain, and other nervous system disorders. alkermes screened the library of compounds from Rensselaer ...

Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study

...ic control.(vi,vii) About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...and Annual Reports on Form 10-K. Amylin, Lilly and alkermes undertake no duty to update these forward-looking ...

After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008

...://www.BYETTA.com . About Amylin, Lilly and Alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once weekly, a subcutaneous injec...sorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, alkermes has research and manufacturing facilities in Massachusetts and Ohio. This...

Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight

...://www.BYETTA.com . About Amylin, Lilly and Alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once weekly, a subcutaneous injec...sorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, alkermes has research and manufacturing facilities in Massachusetts and Ohio. This...
Alkermes in Biological Technology

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer

..., including three successful new drug applications for these products. He has worked with several pharmaceutical and biotechnology companies including alkermes in multiple therapeutic areas, including allergy, asthma, oncology, rheumatology, hematology, diagnostics, and drug delivery systems. "As I join...

Cephalon's New Product Launches Pace Record 2008 Sales

...1.0 million in 2008), charges related to the termination payment due to alkermes ($11.0 million in 2008) and related severance ($1.2 million in 2008), a...8.2 million in 2008), charges related to the termination payment due to alkermes ($11.0 million in 2008) and related severance ($1.2 million in 2008), a...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...ORPORATION (NASDAQ: ADLR ) ALEXION PHARMACEUTICALS INC. (NASDAQ: ALXN ) alkermes INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) ALLOS THERAPEUTICS INC....ERS CORP (NYSE: WAT ) Add ABRAXIS BIOSCIENCE INC NEW (NASDAQ: ABII ) alkermes INC (NASDAQ: ALKS ) AMERISOURCEBERGEN CORP (NYSE: ABC ) APP PHARMACEUTI...

New MedPredict Report Suggests Market for Alcoholism Therapies is Underestimated

...and behavioral diagnostic instruments. Drugs/classes mentioned in this report: ReVia (naltrexone); Vivitrol (extended release injectable naltrexone; alkermes / Cephalon); Campral (acamprosate; Forest); Antabuse (disulfiram); gabapentin (generic); Topamax (topiramate; Ortho-McNeil); Prometa (flumazanil / gab...

Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder

...and now is approved in more than 70 countries worldwide. The treatment uses alkermes proprietary Medisorb(R) technology to deliver and maintain therapeutic medi.... and Janssen-Cilag, a subsidiary of Johnson & Johnson, outside of the U.S. alkermes also developed and manufactures VIVITROL(R), marketed in the U.S. primarily...

Pearl Therapeutics Raises $15.5 Million in Private Financing

... development and commercialization of major products in his prior scientific, engineering and management roles at GlaxoWellcome, Dura Pharmaceuticals, alkermes and Nektar. "We are very pleased to have received strong support from top-tier and sophisticated biopharmaceutical investors," said Mr. Smith. "These...
Other Tags
(Date:7/6/2015)... ... 06, 2015 , ... Understanding the new ICD-10 requirements is ... the transition. ADVOCATE, the only 100% radiology, revenue cycle management company in the ... The ten tips are timely and relevant guidelines to help radiology practices avoid ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... southern California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site health ... other serious medical conditions. Screenings are affordable and accurate and run about an ...
(Date:7/6/2015)... ... July 06, 2015 , ... Seedstock today announced Pierre Sleiman, founder and ... 4th Annual Seedstock Sustainable Agriculture Conference – “Innovation and the Small Farmer” – to ... the University of California-San Diego, will explore solutions and methodologies that small farmers and ...
(Date:7/6/2015)... ... 06, 2015 , ... With a new community program in ... with Family Emergency Shelter Coalition (FESCO) and announced a new charity campaign to ... to provide emergency services and support for homeless families, all the while moving ...
(Date:7/6/2015)... ... 06, 2015 , ... In a split second, breaking a bone can cause ... having a fracture through the bone health screenings conducted by American Bone Health trained ... because our residents need this information to remain independent and strong for many more ...
Breaking Medicine News(10 mins):Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:National Bone Health Screening and Awareness Day 2
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., a ... by the United States Patent and Trademark Office (USPTO) ... process leverages TAKE Solutions, Clinical Accelerators to reduce the ... (when compared to standardization without the accelerators), thus reducing ... At the heart of the patented ...
(Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
(Date:6/23/2015)... RALEIGH, N.C. , June 23, 2015 /PRNewswire/ ... technology, today announced the results of a recent ... unmatched accuracy on the wrist during activity. In ... biometric technology was compared along with the Apple ... for accurately measuring heart rate during activity. The ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
Other Contents